ArticleTherapeutics and clinical risk management2015

Tumor necrosis factor-alpha G-238A polymorphism and coronary artery disease risk: a meta-analysis of 4,222 patients and 4,832 controls.

Xian-Ping Hua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.